Estimating the Impact of Rurality in Disparities in Cancer Mortality
Overview
Affiliations
Purpose: Estimation of the independent effect of rurality on cancer mortality requires causal inference methodology and consideration of area-level socioeconomic status and rural designations.
Methods: Using SEER data, we identified key incident cancers diagnosed between 2000 and 2016 at age ≥20 years (N = 3,788,273), examining a 20% random sample (n = 757,655). Standardized competing risk and survival models estimated the association between rural residence, defined by Rural-Urban Continuum Codes, and cancer-specific and all-cause mortality, controlling for age at cancer diagnosis, sex, race/ethnicity, year of diagnosis, and Area Deprivation Index (ADI). We estimated the attributable fraction (AF) of rurality and high ADI (ADI > median) to the probability of mortality. Finally, we examined county measurement issues contributing to mortality rates discordant from hypothesized rates.
Results: The 5-year standardized failure probability for cancer mortality for rural patients was 33.9% versus 31.56% for urban. The AF for rural residence was 1.04% at year 1 (0.89% by year 5), the highest among local stage disease (Y1 2.1% to Y5 1.9%). The AF for high ADI was 3.33% in Y1 (2.87% in Y5), while the joint effect of rural residence and high ADI was 4.28% in Y1 (3.71% in Y5). Twenty-two percent of urban counties and 30% of rural were discordant. Among discordant urban counties, 30% were only considered urban because of adjacency to metro area. High ADI was associated with urban discordance and low ADI with rural discordance.
Conclusion: Rural residence independently contributes to cancer mortality. The rural impact is the greatest among those with localized disease and in high deprivation areas. Rural-urban county designations may mask high-need urban counties, limiting eligibility to state and federal resources dedicated to rural areas.
He F, Xu R, Zhou D, Zhou X, Chen X Sci Rep. 2025; 15(1):8479.
PMID: 40074844 PMC: 11903829. DOI: 10.1038/s41598-025-93463-x.
The rural disadvantage - prostate cancer outcomes of rural and urban patients over 25 years.
Albers P, Huang G, Bashir S, Mookerji N, Bennett J, Broomfield S J Rural Health. 2025; 41(1):e70008.
PMID: 40029038 PMC: 11874650. DOI: 10.1111/jrh.70008.
Sociodemographic Disparities in Rectal Cancer Outcomes within Academic Cancer Centers.
Kim S, Shen C, El Moheb M, Cummins K, Ruff S, Witt R Ann Surg Oncol. 2025; .
PMID: 40025321 DOI: 10.1245/s10434-025-17085-3.